1. INTRODUCTION
More than two years after the appearance of coronavirus disease 2019
(COVID-19), the relevant research is still ongoing. COVID-19 can lead to
hemostatic disorders and thrombotic diseases due to exaggerated
inflammatory process, decreased tissue oxygenation, and endothelial
dysfunction [1].
Intracardiac thrombi, including tricuspid valve thrombus (TVT), are very
rare life-threatening complications of COVID-19 which indicate high
index of suspicion to provide early proper management [2, 3].
Herein, we report a surgically treated patient with TVT associated with
moderate-to-severe tricuspid regurgitation (TR) during the course of
COVID-19 pneumonia.